Category: Funding Opportunities

NIH – Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01 Clinical Trial Optional)

Purpose: The purpose of this initiative is to support investigator-initiated research on genetic counseling processes and practices in genomic medicine. Research is needed to optimize the genetic counseling process in…

NIH – Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities…

Melanoma Research Alliance – pre-clinical, translational, and early clinical research

Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact,…

NIH – Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Purpose: Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) along with the National Human Genome Research Institute (NHGRI) and National Institute of Dental and Craniofacial Research (NIDCR)…

Stand Up To Cancer (SU2C) – Health Equity Breakthrough Team Research Grant Program

Purpose: The Breakthrough Team represents an unprecedented opportunity to bring together the best scientific minds from diverse fields of research to concentrate on new approaches to address health equity in…

NINDS Exploratory Grant Program in Parkinson’s Disease Research (P20- Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) invites Exploratory Grant (P20) applications for the planning and initiation of collaborative efforts to advance Parkinson's Disease (PD) research. The goal of this program…

NIH – Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)…

NIH – Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations…

NIH – Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)

Purpose: This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity,…

Ovarian Cancer Research Alliance – Multiple Funding Opportunities

Purpose: Ovarian Cancer Research Alliance is the largest global charity funding ovarian cancer research. In the U.S., OCRA is the largest non-government funder of ovarian cancer research.  OCRA grant programs…